Market Status: Closed
  Sunday, 25 Jul '21
   00:26:06 (BST)

A Global Platform to Trade

Securities in Bangladesh



BEXIMCO PHARMACEUTICALS LTD
Trading Code:    BXPHARMA
Scrip Code:    13005
Current Market Information
Last Trade Price (LTP)
Updated Date
Change 0.00 %
Open Price
Day's Range -
   
Total Trade
Total Volume
Close Price
Previous Close Price
Market Capital in BDT (mn) 0.000
   
Contact Information
17, Dhanmondi R/A, Road # 02, Dhaka - 1205
Phone 02-58611891 - 5, 58612040 - 7, 9677701-5
Fax 88 - 02 - 58613470,9615523
Email csdbexim@bol-online.com
Website http://www.beximco-pharma.com
   
Name of the Company Secretary Mohammad Asad Ullah, FCS
Cell no. '01711522029
Telephone No. 58611891-5, 58612040-7 Ext.-10140
Email: csdbexim@bol-online.com
   
Basic Information
Authorized Capital in BDT* (mn) 9,100.00
Paid-up Capital in BDT* (mn) 4,461.12
Face Value 10
Paid up Share 446112089
   
Market Lot 1
Sector PHARMA & CHEMICALS
Market Category A
   
Other Information
Listing Year 1995
Debut Trade Date 06 November, 1995
Type of Instrument
   
52 Week's Range 76.80 - 212.40
Year End 202006
Reserve / Surplus(mn) 21480.44
Remarks 1. As per letter dated 09.02.2010, the company has confirmed that 20,500,000 Preference Shares of Tk. 100.00 each have been converted into 16,169,191 Ordinary Shares.2. As per letter dated 16.06.2010, the company has confirmed that 20,500,000 Preference Shares of Tk. 100.00 each have been converted into 15,121,956 Ordinary Shares.3. Tk. 1,125,767,451 Revaluation Surplus has been added to Reserve and Surplus.
Note
Share Holding Percentage
Sponsor/Director Govt. Institute Foreign Public
As on 31-May, 2021 30.18 0 19.31 30.52 19.99
As on 30-Apr, 2021 30.18 0 19.21 29.66 20.95
As on 31-Mar, 2021 30.18 0 20.19 27.49 22.14
As on 30-Jun, 2021 (year ended) 30.18 0 19.63 30.55 19.64
   
Remarks
Note
   
   
Half Year End (HY) Information  202012
HY Net Turnover(mn)  14400.19
HY Net Profit after tax(mn)  2208.68
HY EPS  4.95
 AGM Information  
AGM Date  19 December, 2020
Record Date  25 November, 2020
Dividend(%)  25.00(15% Cash & 10% Stock)
Bonus Issue  10% 2020,5% 2015, 5% 2014, 5% 2013, 15% 2012, 21% 2011,15% 2009, 20% 2008, 10% 2007, 10% 2006, 25% 2004
Financial Performance
Performance Year Basic EPS Based On Basic EPS (restated) Based On Net Asset Value Per Share Restated Net Asset Value Per Share Net Profit After Tax(mn) % Dividend % Dividend Yield
Continuous operations Including Extra-Ordinary Income Continuous operations Including Extra-Ordinary Income Continuous operations Including Extra-Ordinary Income
2020 8.67 0 0 0 80.12 0 3514.69 0 15%C,10%B 2.17
2019 7.48 0 0 0 72.96 0 3033.4 0 15%C 1.8
2018 6.25 0 0 0 66.78 0 2536.54 0 12.5%C 1.33
2017 5.49 0 0 0 61.82 0 2226.7 0 12.5%C 1.11
2016 2.57 0 0 0 0 0 993.77 0 - 0
 
 Financial Statements
Quarterly Financial Statement
 
Price Sensitive Information
 
Close Price and Traded Volume Graph
Click here to view 1 month graph Click here to view 3 month graph Click here to view 6 month graph